Our Story
TCR-Solutions was established by Davy Yeung in 2015.
Davy is a UK-based academic and clinical research professional who spent many years working in Hospital Research Departments.
This experience led him to the conclusion that CRO-Hospital relationships are often very ‘transactional’. In other words, they are based on contracts and budgets rather than being true partnerships.
Clearly, a paradigm shift was required.
Davy’s objective in setting up TCR-Solutions was to create a CRO that truly understood the needs of hospital sites. They would achieve this by working closely with hospital personnel rather than simply selecting the site and then leaving them to recruit.
Peter MacLennan has spent the majority of his working life in senior clinical research operational and business roles. He joined Davy in early 2016 to support him in the development of a CRO with the infrastructure needed to realise Davy’s ambition.
By utilising their unique knowledge of hospital people, processes and priorities, TCR-Solutions ensures that studies are delivered on time, on budget and to the highest standards of quality.
Our sustained ethos of putting hospital sites at the very heart of what we do means we continue to successfully deliver clinical trials across a wide variety of phases and therapeutic areas.
Highlights include five important and innovative COVID studies; highly complex first-in-man studies; multiple oncology, radiopharmaceutical, gene therapy, psychiatry, and ophthalmology projects; as well as post-marketing RWE programmes. Over the past 18 months, we have also carved out a niche in medical device studies.
